RT @Magil2006: Cochrane Octubre 2020. Trombo profilaxis en pacientes tratados con ASPARRAGINASA @gedefo_sefh @IreneMangues @FarmaOnco htt…
RT @Magil2006: Cochrane Octubre 2020. Trombo profilaxis en pacientes tratados con ASPARRAGINASA @gedefo_sefh @IreneMangues @FarmaOnco htt…
Cochrane Octubre 2020. Trombo profilaxis en pacientes tratados con ASPARRAGINASA @gedefo_sefh @IreneMangues @FarmaOnco https://t.co/K8usvV6d3J
RT @CochraneHaem: Cochrane review identifies the need for high-quality RCTs to assess the benefits and harms of thromboembolism prophylaxis…
RT @CochraneUK: New @CochraneHaem systematic review: Prevention of #bloodclots in adults diagnosed with acute lymphoblastic #leukaemia and…
RT @CochraneHaem: Cochrane review identifies the need for high-quality RCTs to assess the benefits and harms of thromboembolism prophylaxis…
RT @CochraneHaem: Cochrane review identifies the need for high-quality RCTs to assess the benefits and harms of thromboembolism prophylaxis…
RT @CochraneLibrary: New @CochraneHaem systematic review: Prevention of #bloodclots in adults diagnosed with acute lymphoblastic #leukaemia…
RT @CochraneLibrary: New @CochraneHaem systematic review: Prevention of #bloodclots in adults diagnosed with acute lymphoblastic #leukaemia…
New @CochraneHaem systematic review: Prevention of #bloodclots in adults diagnosed with acute lymphoblastic #leukaemia and treated with asparaginase‐based #chemotherapy https://t.co/8bWiAt5GFa
Cochrane review identifies the need for high-quality RCTs to assess the benefits and harms of thromboembolism prophylaxis in adults suffering from acute lymphoblastic leukaemia treated with asparaginase #Cochrane https://t.co/8MhiEkEcGM https://t.co/iylurm